OAR 850-060-0223: Formulary Compendium Exclusions
Edition: Current OARD snapshotEffective: 2023-06-23Last verified: 2026-09-07
The Formulary Council has approved substances as listed by classification in 850-060-0226 for use by Naturopathic physicians in accordance with professional standards of care. (1) This authority does not supersede the education and training requirement established in 850-060-0212 for administration of IV agents or any other education and training required to prescribe, dispense, administer, or order all legend or controlled substances. (2) Additionally, the following substances may not be prescribed by licensees of this Board. (a) General anesthetics (b) Injectable Ketamine for the purpose of general anesthesia (c) Mifepristone and Misoprostol as an abortifacient (d) Barbiturates; with the exception of the following: (A) Phenobarbital (B) Butalbital (C) Primidone (e) Systemic oncology agents with the exception of the following antineoplastic agents, in oral and topical form only. (A) 5FU (B) Anastrozole (C) Letrozole (D) Mechlorethamine (E) Megestrol (F) Mercaptopurine (G) Methotrexate (H) Tamoxifen (I) Tretinoin (f) Any other substance not listed in 850-060-0226 classification or meeting prior approval of the Board.
Official history and status
Statutory/Other Authority: ORS 685.125
Statutes/Other Implemented: ORS 685.030
History: OBNM 2-2023, amend filed 06/23/2023, effective 06/23/2023 OBNM 1-2023, temporary amend filed 01/20/2023, effective 01/20/2023 through 07/17/2023 OBNM 13-2022, amend filed 12/13/2022, effective 01/01/2023 OBNM 5-2018, amend filed 12/20/2018, effective 12/20/2018 OBNM 1-2018, amend filed 02/16/2018, effective 02/16/2018 OBNM 4-2016, f. & cert. ef. 10-12-16
This rule cites
No citations extracted.
Cited by
No inbound citations found.
Official source: https://secure.sos.state.or.us/oard/